Among his many accomplishments is the development of chemical amplification, which enabled the production of modern photoresists and integrated circuits that contributed to the development of modern computers and other electronics. His most recent work has focused on using polymers for therapeutic uses including targeted drug, vaccine, and DNA delivery.
Frchet is the corporate founder of Ardelyx and Aquanano. He has served as a scientific or corporate advisor to some of the world’s largest and most innovative companies, including Unilever, Merck, Novomer, IBM Corporation, Exxon-Mobil, Xerox, Eastman Kodak, Bayer, BASF, DuPont, Amoco, and Novartis.
“Jean Frchet will bring a unique perspective to KAUST that bridges its academic, research, and economic development programs,” said William Rosenzweig, co-founder and managing director of Physic Ventures, a venture capital firm that Frchet has worked with in California. “He has built a solid record of achievement in the business world through a keen understanding of the commercial applications of his groundbreaking work in chemistry and chemical engineering. This innovative and entrepreneurial mindset will serve KAUST well as it pursues its economic mandate in the coming years.”
While at Berkeley, Frchet also worked at Lawrence Berkeley National Laboratory as a principal investigator in the Materials Science Division and the Scientific Director of the Organic and Macromolecular Facility for t
Copyright©2010 Vocus, Inc.
All rights reserved